Skip to the main content.

1 min read

Alcami Appoints President of Laboratory Operations

Alcami Corporation announces the appointment of Katie Schlipp to the role of President of Laboratory Operations.

Wilmington, North Carolina – February 17, 2023 – Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the promotion of Katie Schlipp to President of Laboratory Operations.

Katie brings over 25 years of experience in leading laboratory teams. She started her career with AAIPharma (now Alcami) as an Assistant Scientist in Wilmington, NC, and progressed through every level of the scientific and management career ladder culminating in her appointment as President.

As President of Laboratory Operations, Katie is responsible for Alcami's extensive laboratory network spanning four campus locations offering comprehensive analytical development and method establishment, QC release and stability testing, microbiology, and identification/characterization to support both small molecules and biologics. Katie holds a Bachelor's and Master's of Chemistry from the University of North Carolina at Wilmington.

"During her tenure at Alcami, Katie instituted 5S and lean principles, Key Performance Indicators (KPIs), and implemented training and mentoring solutions within our laboratory operation, which is widely recognized today as one of the top analytical service labs in the world,” commented Chairman and CEO Patrick Walsh. "Katie's proven track record of leading client-focused laboratory operations makes her the ideal choice to lead Alcami's next phase of laboratory operations growth and expansion."

About Alcami
Alcami is a contract development and manufacturing organization headquartered in North Carolina with over 40 years of experience advancing products through every development lifecycle stage. Leveraging 738,000 ft² across the United States, Alcami serves pharmaceutical and biotech companies of all sizes providing customizable and innovative solutions for analytical development, clinical to commercial sterile and oral solid manufacturing, packaging, microbiology, cGMP biostorage, environmental monitoring, and pharmaceutical support services.

3 min read

Alcami Expands Biologics Footprint with Investment in Durham

$10 Million Investment Doubles Laboratory Footprint & Enhances Large Molecule and Cell & Gene Therapy Analytical Service Offering

Read More

2 min read

Alcami Appoints EVP of Drug Product Operations and VP of Laboratory Operations

WILMINGTON, NC – MAY 18, 2020 – Alcami, a North Carolina-based contract development and manufacturing organization (CDMO), today announced the...

Read More

2 min read

Alcami RTP Expansion Nears Completion

MORRISVILLE, N.C., July 28, 2020 -- Alcami, a US-based contract development and manufacturing organization (CDMO), is pleased to announce that its...

Read More